Form 4: Syros Pharmaceuticals Executive Sells 46,657 Shares

A Syros Pharmaceuticals executive, Gerald E Quirk, sold 46,657 shares of common stock at a weighted average price of $0.2212.

Summary

• Gerald E Quirk, Chief Legal & Compliance Officer at Syros Pharmaceuticals, sold 46,657 shares of common stock on November 19, 2024.
• The shares were sold at a weighted average price of $0.2212 per share.
• The sale was executed in multiple transactions with prices ranging from $0.2211 to $0.2249 per share.

Sentiment

Score: 5

Explanation: The document is a routine filing of an executive stock sale, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine Form 4 filing, which is common for executives who sell shares in their company. It does not necessarily indicate a negative outlook for the company.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US.
• Executives selling shares is a common occurrence and does not necessarily indicate a negative outlook for the company.
• The volume of shares sold is not unusual for an executive transaction.

Stakeholder Impact

• The stock sale may have a minor impact on the share price, but it is unlikely to be significant.

Key Dates

Keywords

Syros Pharmaceuticals, stock sale, insider trading, executive, SYRS, Gerald E Quirk